Contemporary Pediatrics week in review: FDA updates, monitoring influenza, and more

Thank you for visiting the Contemporary Pediatrics® website. Take a look at some of our top stories from last week (Monday, January 1 to Friday, January 5, 2024), and click on each link to read and watch anything you may have missed.

1.) FDA: Update on neonatal incubators and potential airborne chemical exposure

New neonatal incubators from Drager and certain GE Healthcare incubators do not need to be run for a week prior to clinical use, according to a healthcare provider update from the FDA.

Click here for the full article.

2.) EUA sought for monoclonal antibody in covid-19 prevention for immunocompromised adults and teens

Biopharmaceutical company, Invivyd, made the request to the FDA for its investigational antibody, VYD222.

Click here for the full article.

3.) Specialty infant formula voluntarily recalled due to possible bacterial contamination

More than 675,000 cans of specialty infant formula for cow’s milk allergy have been voluntarily recalled by Reckitt/Mead Johnson Nutrition because of a possible contamination with Cronobacter sakazakii.

Click here for the full article.

4.) Different methods for monitoring influenza A and SARS-CoV-2 in schools

In 43 of 154 school weeks, air samples were positive for influenza A virus (IAV) while SARS-CoV-2 was positive in air samples in 101 of 154 school weeks.

Click here for the full article.

5.) View our completed RSV Roundtable video series

The 5th and final episode of our RSV Roundtable video series in collaboration with Contagion Live and Contemporary OB/GYN was published this week.

Click here to watch it and to view the entire RSV Roundtable series.

6.) More options and new technology for treating epilepsy and seizures

William Gallentine, DO, explains why he is excited for the year ahead when it comes to epilepsy treatment as new technologies emerge and the treatment landscape changes.

Click here to watch the full interview.